| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.59 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.23 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.23 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |